Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:BSGMNASDAQ:ECORNASDAQ:LUNG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.96+4.6%$3.88$2.34▼$8.79$178.87MN/A202,376 shs193,179 shsBSGMBioSig Technologies$5.74$2.10$0.20▼$7.35$156.67M0.02307,035 shs765,188 shsECORelectroCore$5.36+0.6%$5.83$4.47▼$19.49$39.78M0.9295,204 shs116,391 shsLUNGPulmonx$2.97-3.6%$4.42$2.83▼$9.37$119.57M0.52312,406 shs302,125 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global+6.04%0.00%+16.18%-39.92%+473,999,900.00%BSGMBioSig Technologies-10.59%-1.88%+295.86%+574.50%+187.00%ECORelectroCore+2.90%+6.60%-21.50%-63.19%-16.98%LUNGPulmonx-3.14%+4.05%-13.97%-58.60%-55.81%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ABSGMBioSig Technologies0.7201 of 5 stars1.50.00.00.03.00.80.6ECORelectroCore2.3078 of 5 stars3.52.00.00.01.72.50.6LUNGPulmonx3.3847 of 5 stars4.32.00.00.01.92.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50232.66% UpsideBSGMBioSig Technologies 3.00Buy$2.50-56.45% DownsideECORelectroCore 3.00Buy$25.50375.75% UpsideLUNGPulmonx 2.63Moderate Buy$11.53288.05% UpsideCurrent Analyst Ratings BreakdownLatest ECOR, BSGM, AVR, and LUNG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.155/1/2025LUNGPulmonxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $15.005/1/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$10.00 ➝ $9.005/1/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$17.00 ➝ $17.004/21/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.503/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.003/10/2025LUNGPulmonxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy3/10/2025LUNGPulmonxMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight ➝ Equal Weight3/10/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral ➝ Buy3/10/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$17.00 ➝ $17.00(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.71M65.98N/AN/AN/A∞BSGMBioSig Technologies$26K6,025.90N/AN/A($0.33) per share-17.39ECORelectroCore$26.46M1.50N/AN/A$1.24 per share4.32LUNGPulmonx$87.47M1.37N/AN/A$3.09 per share0.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/ABSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%8/13/2025 (Estimated)ECORelectroCore-$18.83M-$1.56N/AN/AN/A-54.40%-154.45%-69.16%8/6/2025 (Estimated)LUNGPulmonx-$60.84M-$1.44N/AN/AN/A-67.31%-55.36%-33.53%7/30/2025 (Estimated)Latest ECOR, BSGM, AVR, and LUNG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025Q1 2025BSGMBioSig Technologies-$0.05-$0.14-$0.09-$0.14N/AN/A5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million5/7/2025Q1 2025LUNGPulmonx-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ABSGMBioSig TechnologiesN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/AN/AN/ABSGMBioSig TechnologiesN/A0.500.50ECORelectroCoreN/A2.121.87LUNGPulmonx0.407.706.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ABSGMBioSig Technologies7.16%ECORelectroCore26.74%LUNGPulmonx91.04%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ABSGMBioSig Technologies17.03%ECORelectroCore19.70%LUNGPulmonx6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/ABSGMBioSig Technologies5027.30 million14.30 millionNo DataECORelectroCore507.42 million5.35 millionNot OptionableLUNGPulmonx25040.26 million37.24 millionOptionableECOR, BSGM, AVR, and LUNG HeadlinesRecent News About These CompaniesPulmonx Co. (NASDAQ:LUNG) Insider Sells $21,744.11 in StockJune 5 at 8:49 AM | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Sees Large Growth in Short InterestJune 3 at 6:54 PM | marketbeat.comPulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceMay 28, 2025 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by Jacobs Levy Equity Management Inc.May 20, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 19, 2025 | marketbeat.com82,070 Shares in Pulmonx Co. (NASDAQ:LUNG) Purchased by Mercer Global Advisors Inc. ADVMay 15, 2025 | marketbeat.comWhy Pulmonx Corporation’s (LUNG) Stock Is Down 5.82%May 10, 2025 | aaii.comDeerfield Management Company L.P. Series C Purchases New Position in Pulmonx Co. (NASDAQ:LUNG)May 10, 2025 | marketbeat.comIt’s Time to Recognize COPD as a Women’s Health IssueMay 8, 2025 | medscape.comPulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call TranscriptMay 6, 2025 | msn.comPulmonx to Present at the Bank of America Securities 2025 Health Care ConferenceMay 1, 2025 | globenewswire.comQ1 2025 Pulmonx Corp Earnings CallMay 1, 2025 | finance.yahoo.comPulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ...May 1, 2025 | uk.finance.yahoo.comPulmonx projects 20% long-term growth amid expanded initiatives and $12B market opportunityMay 1, 2025 | msn.comPulmonx Corporation (LUNG) Q1 2025 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comPulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue EstimatesApril 30, 2025 | zacks.comPulmonx Reports First Quarter 2025 Financial ResultsApril 30, 2025 | globenewswire.comPulmonx's Earnings OutlookApril 29, 2025 | benzinga.comWhy Pulmonx Corporation’s (LUNG) Stock Is Down 5.09%April 22, 2025 | aaii.comAnalysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), Pulmonx (LUNG)April 10, 2025 | markets.businessinsider.comWhy Pulmonx Corporation’s (LUNG) Stock Is Down 12.59%April 9, 2025 | aaii.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNextracker’s Solar Surge: Will It Shatter Its All-Time High?By Thomas Hughes | May 18, 2025View Nextracker’s Solar Surge: Will It Shatter Its All-Time High?Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?By Jeffrey Neal Johnson | May 22, 2025View Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?By Leo Miller | May 16, 2025View Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?Gold’s Record Run in 2025: Here Are 3 Ways to Ride the SurgeBy Ryan Hasson | May 7, 2025View Gold’s Record Run in 2025: Here Are 3 Ways to Ride the SurgeBroadcom Earnings Preview: AVGO Stock Near Record HighsBy Leo Miller | June 3, 2025View Broadcom Earnings Preview: AVGO Stock Near Record HighsECOR, BSGM, AVR, and LUNG Company DescriptionsAnteris Technologies Global NASDAQ:AVR$4.96 +0.22 (+4.64%) As of 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.BioSig Technologies NASDAQ:BSGM$5.74 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$5.71 -0.03 (-0.52%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.electroCore NASDAQ:ECOR$5.36 +0.03 (+0.56%) Closing price 04:00 PM EasternExtended Trading$5.35 -0.01 (-0.21%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Pulmonx NASDAQ:LUNG$2.97 -0.11 (-3.57%) Closing price 04:00 PM EasternExtended Trading$2.98 +0.00 (+0.17%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast A New All-Time High Is Coming Soon for Credo Technology Group Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
